Are There Any Clinical Trials Involving Glutaminase Inhibitors?
Yes, several clinical trials are currently underway to evaluate the efficacy and safety of glutaminase inhibitors. For instance, trials are exploring the use of drugs like CB-839 (Telaglenastat) in combination with other therapies such as immune checkpoint inhibitors and chemotherapy. These trials are crucial for understanding the full potential of these inhibitors and identifying the most effective treatment combinations.
